Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study

Empana, J·2003·European Heart Journal

Cited by (263)

Items 201–263 of 263

  1. The identification of post-acute patients at risk for hospital readmission: Clinical implications of the LACE index
    Elizabeth Ritt, Nathan P. Taylor · 2016 · Clinical Nursing Studies
  2. Coronary Heart Disease Prognosis Using Machine-Learning Techniques on Patients With Type 2 Diabetes Mellitus
    Angela Pimentel, Hugo Filipe Silveira Gamboa, Isa Maria Almeida, Pedro Matos, Rogério T. Ribeiro, João Filipe Raposo · 2018 · IGI Global eBooks
  3. Prognostic Modelling Studies of Coronary Heart Disease—A Systematic Review of Conventional and Genetic Risk Factor Studies
    Nayla Mohamed Gomaa Nasr, Beáta Soltész, János Sándor, Róza Ádány, Szilvia Fiatal · 2022 · Journal of Cardiovascular Development and Disease
  4. Cardiovascular disease classification based on a multi-classification integrated model
    Aiping Zhang, Guang-xin Wang, Wei Zhang, Jingyu Zhang · 2023 · Networks and Heterogeneous Media
  5. Weak Prediction Power of the Framingham Risk Score for Coronary Artery Disease in Nonagenarians
    Josef Yayan · 2014 · PLoS ONE
  6. Computed tomography to visualise a left coronary artery main stem stent
    Daniel M. Sado, Russell K. Bull, J Radvan · 2006 · Heart
  7. La adopción de los percentiles de riesgo cardiovascular evita la sobreestimación o infraestimación del riesgo cardiovascular calculado con el SCORE
    José Ignacio Cuende, Alfredo Acebal, Azucena Carrera-Camarón, Florentino Salado-Cuadrado, Francisco Díez-Cordero, Ismael Blanco-Urzáiz, María Redondo-Valdeolmillos, Nélida García-Vallejo · 2006 · Revista Española de Salud Pública
  8. Dépistage des anomalies sanguines glucidolipidiques à risque coronarien, de 16 à 19–20 ans. À propos d'une enquête menée chez 599 jeunes volontaires
    Jean Luc De Gennes, Pascale Benlian, CLAUDE DREUX, P. Pelegrin · 2007 · Annales d Endocrinologie
  9. Association of Dyslipidemia and Concomitant Risk Factors with In-Hospital Mortality in Acute Coronary Syndrome in Switzerland
    Dragana Radovanović, Paul Erné, Julian Schilling, G Noseda, Felix F. Gutzwiller · 2005 · Heart Drug
  10. Cardioversion threshold, IRAF and beyond
    Klaartje L. Merckx · 2004 · European Heart Journal
  11. Composite Risk Scores
    Ruth E. Brown, Jennifer Linchee Kuk · 2016 · Springer eBooks
  12. First evaluation using a validated scale of the risk of congestive heart failure among hypertensive patients treated by general practitioners (O-PREDICT survey)
    Albert Alain Hagège, Nacima Demil, Gilles Errieau, Jean‐François Aupetit, François Diévart, Jean‐Jacques Mourad · 2010 · Archives of cardiovascular diseases
  13. Diseño de una escala para la evaluación de calidad metodológica de estudios de pronóstico
    Héctor Losada M, Carlos Manterola, Viviana Pineda N, Manuel Vial G, ANTONIO SANHUEZA R · 2009 · Revista de Cirugía
  14. Predictive Value of Cardiovascular Risk Functions: Limitations and Future Potential
    José Miguel Baena-Díez, Rafel Ramos, Jaume Marrugat · 2009 · Revista Española de Cardiología
  15. Prévention primaire de la maladie athéromateuse : un objectif prioritaire, dépister le haut risque cardiovasculaire
    Alain C. Simon, Gilles N. Chironi · 2007 · EMC - Cardiologie
  16. Coronary Artery Calcification
    Shreenidhi M. Venuraju, Ajay Kumar Yerramasu, Dennis A. Goodman, Avijit Lahiri · 2010 · Elsevier eBooks
  17. Forecasting Life Expectancy and Mortality in Sweden – Some Comments on Methodological Problems and Potential Approaches
    Måns Rosén · 2019 · Demographic research monographs
  18. Noninvasive Assessments of Atherosclerosis for Risk Stratification
    Patrick J. Devine, Allen J. Taylor · 2009 · Elsevier eBooks
  19. Cardiale aandoeningen
    J. L. van Dijk, P. J. Senden · 2001 · Bohn Stafleu van Loghum eBooks
  20. Coronary Heart Disease Prognosis Using Machine-Learning Techniques on Patients With Type 2 Diabetes Mellitus
    Angela Pimentel, Hugo Filipe Silveira Gamboa, Isa Maria Almeida, Pedro Matos, Rogério T. Ribeiro, João Filipe Raposo · 2017 · Advances in computational intelligence and robotics book series
  21. Frecuencia del síndrome metabólico y estratificación del riesgo cardiovascular en pacientes con VIH mediante tres sistemas de puntuación
    Luis Dulcey, Jhon Fredy Castillo-Blanco, Juan Sebastián Theran León, Raimondo Caltagirone, Jonathan Antonio Pineda Parada · 2022 · Revista Investigación en Salud Universidad de Boyacá
  22. Estimación del riesgo cardiovascular en Colombia: ¿qué tan cerca estamos?
    Jaime E. Murillo · 2014 · Revista Colombiana de Cardiología
  23. A pharmacoepidemiological study of lipid-lowering drugs in Norway
    Ingeborg Hartz · 2006 · NORA - Norwegian Open Research Archives
  24. Screening for cardiovascular disease
    Anthony S. Wierzbicki · 2004 · European Heart Journal
  25. The role of genetic predisposition and biomarkers in atherosclerosis
    Gerd Assmann, H. Schulte, Udo Seedorf · 2007 · International Congress Series
  26. TWO-YEAR INCIDENCE OF ACUTE FATAL AND NON-FATAL CORONARY EVENTS AND STROKE: IRANIAN POPULATION OVER 35 YEARS OLD
    Babak Sabet, Roya Derakhshan, Masomeh Sadeghi, Nizal Sarrafzadegan, Fateme Derakhshan, S Y Saeidi Hosseini, Abdolmehdi Baghaei, Ahmad Amani, Mohammad Milani · 2005
  27. Perioperative risk estimation using survival epidemiology
    J. B. Carlisle · 2008
  28. Predicting acquired cardiovascular disease in adults with congenital heart disease is risky business
    George K. Lui, Ami B. Bhatt · 2018 · International Journal of Cardiology
  29. E-monitoring solutions for sleep apnea diagnosis and blood pressure measurement
    Remo Lazazzera · 2020
  30. Prevalência da aterosclerose subclínica em mulheres na pós-menopausa com risco cardiovascular baixo e intermediário estimado pelo escore de Framingham
    Ana Cláudia Gomes Pereira Petisco · 2014
  31. Coronary heart disease in the Netherlands : incidence, etiology and risk prediction
    Audrey H. H. Merry · 2010 · Research Publications (Maastricht University)
  32. New Concepts for Early Diagnosis of Coronary Artery Disease
    Sigmund Silber, P. Mathes · 2007 · Springer eBooks
  33. Co-existing disease in vascular surgery patients
    J. B. Carlisle · 2012 · Cambridge University Press eBooks
  34. Risk Identification and Reduction Strategies in Surgical Patients
    Martin Dunkelgrün · 2009 · RePub (Erasmus University Rotterdam)
  35. Screening for cardiovascular disease: reply
    Jean Philippe Empana · 2004 · European Heart Journal
  36. Bias in the evaluation of evidence linking depression to cardiovascular mortality: reply
    Ralph Stewart · 2004 · European Heart Journal
  37. Cholestérol et sujets âgés
    P. Friocourt · 2007 · NPG. Neurologie, psychiatrie, gériatrie/NPG
  38. Prevalência de doença periodontal e estratificação do risco cardiovascular de Framingham e PROCAM de pacientes do Instituto Dante Pazzanese de Cardiologia
    Leopoldo Penteado Nucci da Silva · 2008
  39. Cálculo del riesgo coronario en atención primaria: ¿qué tabla es más adecuada para nuestros pacientes?
    Diana Rodríguez Villar, Lorena Muñoz Devesa, Ulpiano López · 2007 · Atención Primaria
  40. Towards Genetic Prediction of Coronary Heart Disease in Familial Hypercholesterolemia
    Jeroen van der Net · 2009 · RePub (Erasmus University Rotterdam)
  41. EVALUATION OF CORONARY RISK SCORE APPLICATIONS IN 10-YEAR CORONARY HEART RISK ESTIMATION ISPITIVANJE ZNA^AJA PRIMENE BODOVNIH SISTEMA ZA PROCENU UKUPNOG 10-GODI(NJEG RIZIKA ZA KORONARNU BOLEST SRCA
    Nevena Eremi · 2009
  42. Išeminės širdies ligos rizikos susirgti nustatymas skirtingais metodais ISCHAEMIC HEART DISEASE RISK ASSESMENT OF ASYMPTOMATIC PATIENTS BY DIFFERENT METHODS
    Donatas Antanas Vasiliauskas · 2007
  43. LA ADOPCIÓN DE LOS PERCENTILES DE RIESGO CARDIOVASCULAR EVITA LA SOBREESTIMACIÓN O INFRAESTIMACIÓN DEL RIESGO CARDIOVASCULAR CALCULADO CON EL SCORE
    Servicio de Medicina, Hospitalario de Palencia · 2006
  44. Understanding and managing cardiovascular disease risk factors in Vietnam : integrating clinical and public health perspectives
    Quang Ngoc Nguyen · 2012 · DiVA at Umeå University (Umeå University)
  45. Impact of Co-morbidites, Physiological Status and Age on Survival
    J. B. Carlisle · 2016 · Springer eBooks
  46. Estimación del riesgo cardiovascular en Colombia: ¿qué tan cerca estamos? Cardiovascular risk estimation in Colombia: how close are we?
    Jaime E. Murillo · 2014
  47. Riesgo cardiovascular global y diagnóstico por imágenes de la ateroesclerosis
    Fernando Florenzano U. · 2008 · Revista Médica Clínica Las Condes
  48. Early evaluation of the development of cardiovascular pathology in asymptomatic patients with subclinical hypothyroidism
    Oleg Shekera, Kh.M. Кukharchuk · 2018 · Family Medicine
  49. Behavioural and biological predictors of depression in older age: The role of internet use, insulin-like growth factor 1, and cardiovascular disease risk factors in the English Longitudinal Study of Ageing
    Sungano Chigogora · 2018 · UCL Discovery (University College London)
  50. Spiroergometrie in der erweiterten flugmedizinischen kardiovaskulären Beurteilung
    Claus Steppert, Christian Stumpf · 2019 · Flugmedizin · Tropenmedizin · Reisemedizin - FTR
  51. Knowledge, attitude and practice of family physician regarding global cardiovascular risk assessment in PSMMC primary health care centers in Riyadh, Saudi Arabia
    Salman Dhaher Alenezi, Osama Samir Almansouri, Mostafa Abbas Kofi · 2021 · International Journal of Advanced Community Medicine
  52. The new Zealand
    Robin Smith Warren Jacbs, G. C. BILLING. · 2018
  53. Prediabetes Prediction Using Response Surface Methodology and Probabilistic Neural Networks Model in an Ethnic South Indian Population
    Raja Das, Shree G B Bakhya, Vijay Viswanathan, Radha Saraswathy, K. Madhusudhan Reddy · 2024 · Studies in computational intelligence
  54. Imaging Atherosclerosis for Risk Stratification by Cardiac Computed Tomography or Carotid Ultrasound
    Allen J. Taylor · 2015 · Elsevier eBooks
  55. Recalibration of the Framingham coronary heart disease risk score for a selected Sri Lankan population and its association with carotid artery intima-media thickness: A cross-sectional study
    Visula Abeysuriya, Prakash P. Priyadharshan, Lal Gotabhaya Chandrasena, Ananda Rajitha Wickremasinghe · 2025 · JRSM Cardiovascular Disease
  56. Cardiovascular risk prediction in Central and Eastern Europe and former Soviet Union
    Olga Vikhireva · 2012 · UCL Discovery (University College London)
  57. Additional file 1 of Cardiovascular risk assessment methods yield unequal risk predictions: a large cross-sectional study in psychiatric secondary care outpatients
    Davy M C Quadackers, Edith Jantine Liemburg, Fionneke Marijke Bos, Bennard Doornbos, Arne Risselada, Marjolein Y. Berger, Ellen Visser, Daniëlle C. Cath · 2023 · Figshare
  58. Additional file 2 of Cardiovascular risk assessment methods yield unequal risk predictions: a large cross-sectional study in psychiatric secondary care outpatients
    Davy M C Quadackers, Edith Jantine Liemburg, Fionneke Marijke Bos, Bennard Doornbos, Arne Risselada, Marjolein Y. Berger, Ellen Visser, Daniëlle C. Cath · 2023 · Figshare
  59. Cardiovascular disease risk assessment in the general population: rationale for selection of prognostic model regarding age
    А.П. Шепелькевич, Д.Д. Баалбаки, A. Pristrom, Alena Yurenia · 2026 · Healthcare
  60. De la dose à l'effet clinique : utilisation de la modélisation dans les différentes étapes du processus de prédiction du critère clinique : Exemple avec un nouveau médicament en prévention secondaire de la morbidité-mortalité cardiovasculaire
    Florence Hourcade‐Potelleret · 2012 · theses.fr (ABES)
  61. Estrogènes endogènes et risque cardiovasculaire chez les femmes ménopausées
    Valérie Scarabin‐Carré · 2015
  62. Épidémiologie des facteurs de risque cardiovasculaire en population tropicale - cas du Bénin
    Yessito Corine Nadège Yessito Corine Nadège Houehanou Sonou · 2015 · theses.fr (ABES)
  63. Risco cardiovascular em doentes infectados por Vírus da Imunodeficiência Humana
    Emília Valadas, S. Sousa, F. Antunes · 2009 · Revista Portuguesa de Doenças Infecciosas (RPDI)